MP
Mirum Pharmaceuticals Inc
🇩🇪XFRA.08DGermanyHealthcare
€81.04EURdown -1.34 (-1.63%)ClosedEnd of day8:57 PM
Price€81.04-1.34 (-1.63%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US6047491013
- CUSIP
- Not reported
Company
- Employees
- 433
- Headquarters
- Foster City, United States
- Website
- https://www.mirumpharma.com
- CEO
- Mr. Christopher Peetz
Market
- Shares outstanding
- 64.9M
- Market cap
- €5.26B
Key dates
- Next earnings
- Nov 4, 2026
Highlights
- Market cap
- €5.26B
- EPS LTM
- -$13.57
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $618.07M+44.02%up year on year
- Net income
- -$860.21M-1,368.86%down year on year
- Gross margin
- 81.7%+3.39%up year on year
- Free cash flow
- -$458.17M-33,269.85%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.